About Us
Management Team
Prof. Jean Paul THIERY
Chairman & Scientific Founder
- Awardee of Knight of French National Order of Merit (1997), Laureate of French Academy of Medicine (2000) & Knight in the French Legion of Honor (2009)
- World’s Top 2% Scientists Ranking in Clinical Medicine (Elsevier, 2022)
- Author of more than 565 peer-reviewed original research articles (h-index: 130) and holder of 5 patents
- Pioneer in the field of EMT in oncogenesis and seminal contribution to bladder cancer carcinoma
Dr. Kian Chung LEE, PhD
Co-Founder / CEO
- Translational scientist in cancer immuno-diagnostics
- Technology lead with 23 years of academic & industry experience specializing in antibody usage for diagnostics & research in Merck Sharpe & Dohme Research Labs and A*STAR labs
- Winner of Singapore-MIT Alliance (1st Prize) Impact Bootcamp: Entrepreneurship from Technology to Impact for bringing the bladder cancer work from bench to bedside
Dr. Ervinna PANG, PhD, CVA
Chief Business Officer
- 18 years of experiences in Life Science and Healthcare sector in the areas of strategic partnerships, technology commercialization, business development and venture investments.
- Industry veteran with global pharmaceutical companies (Bayer and Boehringer Ingelheim), early and growth stage Biotech and Medtech companies as well as technology transfer offices/commercialization arms of A*STAR and Nanyang Technological University, Singapore.
- Chartered Valuer and Appraiser in valuing intangible assets/Intellectual Property and Enterprise value.
Mr. Vincent CHEUNG
Chief Operating Officer
- Industry veteran with more than 25 years of medical device product development and manufacturing experiences
- Implemented QMS for 40+ Medtech startups in commercializing technologies ranging from SaMD & medical electrical equipment to implantable devices and IVD assays
- Transferred medical technologies and manufacturing operations (US, Singapore, Malaysia) for Class 2 & 3 devices with successful ISO13485 QMS certification and FDA inspection